Step 1: Understanding the Concept:
Different antimalarial drug classes kill Plasmodium through very different mechanisms, and this question is asking which mechanism belongs specifically to artemisinin.
Step 2: Key Concept or Approach:
Artemisinin's structure carries a unique endoperoxide bridge not found in older antimalarials, and that structural feature is the key to identifying its mechanism among the four options.
Step 3: Detailed Explanation:
Dihydrofolate reductase inhibition belongs to antifolates like pyrimethamine, a completely different drug class from artemisinin.
Heme polymerase inhibition, which lets toxic free heme build up, is the mechanism of chloroquine and related quinolines, not artemisinin.
A specific action on parasite ATPase has been studied but is not the accepted primary mechanism for artemisinin.
Inside the infected red blood cell, iron released from hemoglobin breakdown reacts with artemisinin's endoperoxide bridge, splitting it and releasing reactive oxygen species and carbon radicals that attack parasite proteins and membranes, killing the parasite.
Step 4: Final Answer:
Artemisinin works by iron-catalyzed cleavage of its endoperoxide bridge, generating reactive oxygen species that destroy the parasite.